Skip to content

Effect of Autologous Fat Grafting on Acute Burn Wound Healing

Effect of Autologous Fat Grafting and Nanofat Usage on Burn Wound Healing and Early Scarring

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03791710
Enrollment
100
Registered
2019-01-03
Start date
2019-03-14
Completion date
2020-01-31
Last updated
2020-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Brief summary

the study evaluates the role of autologous fat grafting and the usage of nanofat in the treatment of the acute burn injuries in different genders and its influences on the healing time and hospital stay, pain control, the need and take of a split thickness skin graft and its size, and the end resulting early scarring, in comparison with control group that were treated with traditional methods, so as to find out new method of treating burn injuries and decreasing its morbidity.

Detailed description

as the patient is admitted, full evaluation locally ( as regard the wound itself and the areas of fat harvesting) and generally (assessment of the general condition) is done, fluid resuscitation is started as the unit protocol hand in hand with the analgesia and other medications prescribed according to the unit protocol. the patient's general condition is optimized for surgery of the fat extraction and grafting which typically should be within the first 6 days of admission. then under anesthesia (any possible type from local and regional up to general anesthesia) liposuction procedure is performed, then fat is processed then grafted at the wound site with other portion prepared as nanofat for topical use and wound coverage, then sterile dressing is applied. typically follow up is held daily with the dressing change day after another with the use of the nanofat only and sterile dressing

Interventions

regular liposuction procedure at which sufficient amount of fat is extracted from the patient and then the fat is processed then grafted underneath the burn wound

serial dressing with topical agents e.g Silver Sulphadiazine

depridment and split thickness skin grafting

Sponsors

Ahmed Mohamed Abouzaid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

two groups one will have the fat grafting and the other will be the control group treated with the conventional methods

Eligibility

Sex/Gender
ALL
Age
13 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* both males and females within the age frame are candidates. * previously healthy individuals with no co-morbid conditions e.g cardiac, hepatic, diabetic, vascular or renal disease. * with TBSA of 10 to 30% affected and of deep dermal to full thickness wound depth, at any part of the body except the genitalia, perineum or the perianal region or those with inhalational injury.

Exclusion criteria

* other patients aged younger or older than the specified age group. * patients with co-morbid conditions. * patients with smaller or larger BSA than the specified BSA. * burns involving the genitalia, perineum or the perianal region and patients with inhalational injury.

Design outcomes

Primary

MeasureTime frameDescription
wound healing timeone to three weeksthe effect of the fat grafting on the wound healing time

Secondary

MeasureTime frameDescription
effect on pain perception, subjective assessment scaleimmediate post-operative and up to three weekseffect of the fat grafting on the pain sensation in the burn wound, assessment through a numerical scale starting at 0 indicating no pain at all to 10 the most intense severe pain. the range between 1 and 3 describes mild pain, between 4 and 6 describes moderate pain, and lastly from 7 to 10 severe pain.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026